α -MSH Modulates Experimental Inflammatory Bowel Disease
- 1 January 1997
- Vol. 18 (3) , 381-385
- https://doi.org/10.1016/s0196-9781(96)00345-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The neuropeptide α-MSH has specific receptors on neutrophils and reduces chemotaxis in vitroPeptides, 1996
- Endogenous cytokine antagonists during myocardial ischemia and thrombolytic therapyAmerican Heart Journal, 1995
- Sulfhydryl blocker-induced rat colonic inflammation is ameliorated by inhibition of nitric oxide synthaseGastroenterology, 1995
- Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependentDigestive Diseases and Sciences, 1995
- Endotoxin Causes Release of α-Melanocyte-Stimulating Hormone in Normal Human SubjectsNeuroimmunomodulation, 1995
- Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cellsPublished by Elsevier ,1994
- The Neuropeptide Alpha-Melanocyte-Stimulating Hormone: A Key Component NeuroimmunomodulationNeuroimmunomodulation, 1994
- The Neuropeptide Alpha-Melanocyte-Stimulating Hormone Inhibits Experimental Arthritis in RatsNeuroimmunomodulation, 1994
- Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease.Gut, 1993
- Tumor necrosis factor-?, interleukin-1?, and interleukin-6 expression in inflammatory bowel diseaseDigestive Diseases and Sciences, 1992